Key result
The MitraClip NT system is safe and effective for treating severe mitral regurgitation in patients with cardiogenic shock, especially when supported by an intra-aortic balloon pump.
Percutaneous mitral valve repair using the MitraClip NT system, supported by an intra-aortic balloon pump, may be a feasible and safe option for patients with severe mitral regurgitation and cardiogenic shock.
May support bailout in refractory cardiogenic shock; hypothesis-generating and should not yet change practice.
The MitraClip NT™ system for the treatment of severe mitral valve regurgitation is effective and safe - even for patients suffering from cardiogenic shock. The use of an intra-aortic balloon pump expands the range of possible applications to this particular group of challenging patients.
No takes yet. Share an insight, caveat, or question.
Buckert et al. (2017) studied this question. The MitraClip NT system is safe and effective for treating severe mitral regurgitation in patients with cardiogenic shock, especially when supported by an intra-aortic balloon pump.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: